Octagon Capital Advisors as of March 31, 2026
Portfolio Holdings for Octagon Capital Advisors
Octagon Capital Advisors holds 29 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Dianthus Therapeutics (DNTH) | 18.1 | $163M | 1.9M | 83.92 | |
| Cogent Biosciences (COGT) | 10.0 | $91M | 2.4M | 38.49 | |
| Abivax Sa Sponsored Ads (ABVX) | 8.3 | $75M | 677k | 111.35 | |
| Alumis (ALMS) | 6.9 | $62M | 2.8M | 22.03 | |
| Definium Therapeutics Com Shs (DFTX) | 5.1 | $46M | 2.4M | 18.90 | |
| Arrivent Biopharma (AVBP) | 5.0 | $46M | 2.0M | 23.07 | |
| Taysha Gene Therapies Com Shs (TSHA) | 4.4 | $40M | 8.9M | 4.47 | |
| Kymera Therapeutics (KYMR) | 3.9 | $35M | 425k | 83.29 | |
| Mirum Pharmaceuticals (MIRM) | 3.5 | $31M | 339k | 92.38 | |
| Bioage Labs (BIOA) | 3.4 | $31M | 1.7M | 17.49 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 3.3 | $30M | 750k | 39.72 | |
| Kalvista Pharmaceuticals (KALV) | 3.2 | $29M | 1.5M | 20.13 | |
| Xenon Pharmaceuticals (XENE) | 3.2 | $29M | 490k | 58.15 | |
| Terns Pharmaceuticals (TERN) | 3.1 | $28M | 530k | 52.72 | |
| Ocular Therapeutix (OCUL) | 3.0 | $27M | 3.2M | 8.47 | |
| Palisade Bio (PALI) | 2.0 | $18M | 10M | 1.75 | |
| Trevi Therapeutics (TRVI) | 2.0 | $18M | 1.5M | 11.93 | |
| Disc Medicine (IRON) | 1.9 | $17M | 270k | 63.94 | |
| Aktis Oncology | 1.9 | $17M | 961k | 17.89 | |
| Context Therapeutics (CNTX) | 1.5 | $14M | 5.3M | 2.62 | |
| Precision Biosciences Com New (DTIL) | 1.4 | $12M | 2.2M | 5.50 | |
| Dbv Technologies S A Sponsored Ads (DBVT) | 1.3 | $12M | 574k | 20.89 | |
| Unicycive Therapeutics Com New (UNCY) | 0.7 | $6.6M | 1.0M | 6.58 | |
| Bridgebio Oncology Therapeut Com New (BBOT) | 0.7 | $6.4M | 719k | 8.95 | |
| Lexeo Therapeutics (LXEO) | 0.7 | $6.3M | 1.1M | 5.74 | |
| Pharvaris N V (PHVS) | 0.5 | $4.7M | 165k | 28.25 | |
| Perspective Therapeutics Com New (CATX) | 0.4 | $3.3M | 792k | 4.17 | |
| Evommune Com Shs (EVMN) | 0.4 | $3.3M | 144k | 22.99 | |
| Gossamer Bio (GOSS) | 0.3 | $2.5M | 7.8M | 0.33 |
